Treating atherosclerosis: targeting risk factors should not be the only option

Ann Transl Med. 2018 Nov;6(Suppl 1):S34. doi: 10.21037/atm.2018.09.40.

Montserrat Fibla¹, Anna Hernández-Aguilera^{1

2}, Jordi Camps^{1

2}, Javier A Menendez^{3

4}, Jorge Joven^{1

2

5}

¹ Universitat Rovira i Virgili, Department of Medicine and Surgery, Reus, Spain.
² Unitat de Recerca Biomèdica (URB-CRB), Hospital Universitari de Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Reus, Spain.
³ Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain.
⁴ Girona Biomedical Research Institute (IDIBGI), Girona, Spain.
⁵ The Campus of International Excellence Southern Catalonia, Tarragona, Spain.

No abstract available

Publication types